Analysis

A request to WTO to extend waiver for pharmaceutical products

As civil society organizations concerned with ensuring prompt availability of affordable medicines in Least Developed Countries (LDCs) we call on World Trade Oorganization (WTO) Members to unconditionally accord the LDC Group an extension of the transition period with respect to pharmaceutical products and waivers from obligations under Article 70.8 (mailbox obligation) and Article70.9 (exclusive marketing rights) as requested in their duly motivated request to the TRIPs Council (IP/C/W/605).

To read the letter in full (English, Spanish and French):
CSO letterFinal, CSO letterSP, CSO letterFR

1 reply »

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.